{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:40:48Z","timestamp":1787020848633,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Current goals in the acute treatment of heart failure are focused on pulmonary and systemic decongestion with loop diuretics as the cornerstone of therapy. Despite rapid relief of symptoms in patients with acute decompensated heart failure, after intravenous use of loop diuretics, the use of these agents has been consistently associated with adverse events, including hypokalemia, azotemia, hypotension, and increased mortality. Two recent randomized trials have shown that continuous infusions of loop diuretics did not offer benefit but were associated with adverse events, including hyponatremia, prolonged hospital stay, and increased rate of readmissions. This is probably due to the limitations of congestion evaluation as well as to the deleterious effects linked to drug administration, particularly at higher dosage. The impaired renal function often associated with this treatment is not extensively explored and could deserve more specific studies. Several questions remain to be answered about the best diuretic modality administration, global clinical impact during acute and post-discharge period, and the role of renal function deterioration during treatment. Thus, if loop diuretics are a necessary part of the treatment for acute heart failure, then there must be an approach that allows personalization of therapy for optimal benefit and avoidance of adverse events.<\/jats:p>","DOI":"10.1186\/s13054-015-1017-3","type":"journal-article","created":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T08:05:36Z","timestamp":1439885136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Loop diuretics in acute heart failure: beyond the decongestive relief for the kidney"],"prefix":"10.1186","volume":"19","author":[{"given":"Alberto","family":"Palazzuoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Ruocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Ronco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,1]]},"reference":[{"key":"1017_CR1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs033","volume":"14","author":"JJ McMurray","year":"2012","unstructured":"McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, B\u00f6hm M, Dickstein K, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803\u201369.","journal-title":"Eur J Heart Fail"},{"key":"1017_CR2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","volume":"149","author":"KF Adams Jr","year":"2005","unstructured":"Adams Jr KF, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149:209\u201316.","journal-title":"Am Heart J"},{"key":"1017_CR3","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0735-1097(03)00309-7","volume":"41","author":"A Nohria","year":"2003","unstructured":"Nohria A, Tsang SW, Fang JC, Lewis EF, Jarcho JA, Mudge GH, et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol. 2003;41:1797\u2013804.","journal-title":"J Am Coll Cardiol"},{"key":"1017_CR4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jacc.2008.10.041","volume":"53","author":"M Gheorghiade","year":"2009","unstructured":"Gheorghiade M, Pang PS. Acute heart failure syndromes. J Am Coll Cardiol. 2009;53:557\u201373.","journal-title":"J Am Coll Cardiol"},{"key":"1017_CR5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10741-011-9245-3","volume":"17","author":"GM Felker","year":"2012","unstructured":"Felker GM. Loop diuretics in heart failure. Heart Fail Rev. 2012;17:305\u201311.","journal-title":"Heart Fail Rev"},{"key":"1017_CR6","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/eurheartj\/ehu065","volume":"35","author":"MA Valente","year":"2014","unstructured":"Valente MA, Voors AA, Damman K, Van Veldhuisen DJ, Massie BM, O\u2019Connor CM, et al. Diuretic response in acute heart failure: clinical characteristics and prognostic significance. Eur Heart J. 2014;35:1284\u201393.","journal-title":"Eur Heart J"},{"key":"1017_CR7","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ejheart.2007.07.011","volume":"9","author":"V Hasselblad","year":"2007","unstructured":"Hasselblad V, Stough WG, Shah MR, Lokhnygina Y, O\u2019Connor CM, Califf RM, et al. Relation between dose of loop diuretics and outcomes in heart failure population: results of the ESCAPE trial. Eur J Heart Fail. 2007;9:1064\u20139.","journal-title":"Eur J Heart Fail"},{"key":"1017_CR8","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2006.09.011","volume":"119","author":"M Gheorghiade","year":"2006","unstructured":"Gheorghiade M, Filippatos G, De Luca L, Burnett J. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med. 2006;119:S3\u2013S10.","journal-title":"Am J Med"},{"key":"1017_CR9","first-page":"697","volume":"20","author":"LE Rohde","year":"2004","unstructured":"Rohde LE, Beck-da-Silva L, Goldraich L, Grazziotin TC, Palombini DV, Polanczyk CA, et al. Reliability and prognostic value of traditional signs and symptoms in outpatients with congestive heart failure. Can J Cardiol. 2004;20:697\u2013702.","journal-title":"Can J Cardiol"},{"key":"1017_CR10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10741-014-9438-7","volume":"20","author":"G Parrinello","year":"2015","unstructured":"Parrinello G, Greene SJ, Torres D, Alderman M, Bonventre JV, Di Pasquale P, et al. Water and sodium in heart failure: a spotlight on congestion. Heart Fail Rev. 2015;20:13\u201324.","journal-title":"Heart Fail Rev"},{"key":"1017_CR11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejheart.2008.01.007","volume":"10","author":"G Cotter","year":"2008","unstructured":"Cotter G, Metra M, Milo-Cotter O, Dittrich HC, Gheorghiade M. Fluid overload in acute heart failure\u2014re-distribution and other mechanisms beyond fluid accumulation. Eur J Heart Fail. 2008;10:165\u20139.","journal-title":"Eur J Heart Fail"},{"key":"1017_CR12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2007.09.043","volume":"51","author":"W Mullens","year":"2008","unstructured":"Mullens W, Abrahams Z, Skouri HN, Francis GS, Taylor DO, Starling RC, et al. Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol. 2008;51:300\u20136.","journal-title":"J Am Coll Cardiol"},{"key":"1017_CR13","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.jacc.2005.11.084","volume":"47","author":"GL Smith","year":"2006","unstructured":"Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, DiCapua P, et al. Renal impairment and outcomes in heart failure systematic review and meta-analysis. J Am Coll Cardiol. 2006;47:1987\u201396.","journal-title":"J Am Coll Cardiol"},{"key":"1017_CR14","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.cardfail.2007.03.011","volume":"13","author":"JT Heywood","year":"2007","unstructured":"Heywood JT, Fonarow GC. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE Database. J Card Fail. 2007;13:422\u201330.","journal-title":"J Card Fail"},{"key":"1017_CR15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCHEARTFAILURE.107.746933","volume":"1","author":"L Klein","year":"2008","unstructured":"Klein L, Massie BM, Leimberger JD, O\u2019Connor CM, Pi\u00f1a IL, Adams Jr KF, et al. Admission or changes in renal function during hospitalization for worsening heart failure predict post discharge survival. Results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). Circ Heart Fail. 2008;1:25\u201333.","journal-title":"Circ Heart Fail"},{"key":"1017_CR16","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejheart.2008.01.011","volume":"10","author":"M Metra","year":"2008","unstructured":"Metra M, Nodari S, Parrinello G, Bordonali T, Bugatti S, Danesi R, et al. Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail. 2008;10:188\u201395.","journal-title":"Eur J Heart Fail"},{"key":"1017_CR17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.cardfail.2010.02.001","volume":"16","author":"D Aronson","year":"2010","unstructured":"Aronson D, Burger AJ. The relationship between transient and persistent worsening renal function and mortality in patients with acute decompensated heart failure. J Card Fail. 2010;16:541\u20137.","journal-title":"J Card Fail"},{"key":"1017_CR18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.amjcard.2010.08.045","volume":"107","author":"DE Lanfear","year":"2011","unstructured":"Lanfear DE, Peterson EL, Campbell J, Phatak H, Wu D, Wells K, et al. Relation of worsened renal function during hospitalization for heart failure to long-term outcomes and rehospitalization. Am J Cardiol. 2011;107:74\u20138.","journal-title":"Am J Cardiol"},{"key":"1017_CR19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/CIRCULATIONAHA.109.933275","volume":"122","author":"JM Testani","year":"2010","unstructured":"Testani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation. 2010;122:265\u201372.","journal-title":"Circulation"},{"key":"1017_CR20","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/eurjhf\/hfr070","volume":"13","author":"JM Testani","year":"2011","unstructured":"Testani JM, Coca SG, McCauley BD, Shannon RP, Kimmel SE. Impact of changes in blood pressure during the treatment of acute decompensated heart failure on renal and clinical outcomes. Eur J Heart Fail. 2011;13:877\u201384.","journal-title":"Eur J Heart Fail"},{"key":"1017_CR21","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","volume":"364","author":"GM Felker","year":"2011","unstructured":"Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011;364:797\u2013805.","journal-title":"N Engl J Med"},{"key":"1017_CR22","doi-asserted-by":"crossref","first-page":"R134","DOI":"10.1186\/cc13952","volume":"18","author":"A Palazzuoli","year":"2014","unstructured":"Palazzuoli A, Pellegrini M, Ruocco G, Martini G, Franci B, Campagna MS, et al. Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial. Crit Care. 2014;18:R134.","journal-title":"Crit Care"},{"key":"1017_CR23","first-page":"e25","volume":"20","author":"E Raichlin","year":"2014","unstructured":"Raichlin E, Haglund NA, Dumitru I, Lyden ER, Johnston MD, Mack JM, et al. Worsening renal function in patients with acute decompensated heart failure treated with ultrafiltration: predictors and outcomes. J Card Fail. 2014;20:e25\u201332.","journal-title":"J Card Fail"},{"key":"1017_CR24","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1001\/jama.2013.282190","volume":"310","author":"HH Chen","year":"2013","unstructured":"Chen HH, Anstrom KJ, Givertz MM, Stevenson LW, Semigran MJ, Goldsmith SR, et al. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA. 2013;310:2533\u201343.","journal-title":"JAMA"},{"key":"1017_CR25","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1136\/hrt.72.2_Suppl.S40","volume":"72","author":"DC Brater","year":"1994","unstructured":"Brater DC. Pharmacokinetics of loop diuretics in congestive heart failure. Br Heart J. 1994;72:S40\u20133.","journal-title":"Br Heart J"},{"key":"1017_CR26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0735-1097(90)90196-V","volume":"15","author":"LW Stevenson","year":"1990","unstructured":"Stevenson LW, Brunken RC, Belil D, Grover-McKay M, Schwaiger M, Schelbert HR, et al. Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure. J Am Coll Cardiol. 1990;15:174\u201380.","journal-title":"J Am Coll Cardiol"},{"key":"1017_CR27","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jacc.2011.01.052","volume":"58","author":"JM Testani","year":"2011","unstructured":"Testani JM, Cappola TP, Brensinger CM, Shannon RP, Kimmel SE. Interaction between loop diuretic-associated mortality and blood urea nitrogen concentration in chronic heart failure. J Am Coll Cardiol. 2011;58:375\u201382.","journal-title":"J Am Coll Cardiol"},{"key":"1017_CR28","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ahj.2003.08.012","volume":"147","author":"J Butler","year":"2004","unstructured":"Butler J, Forman DE, Abraham WT, Gottlieb SS, Loh E, Massie BM, et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J. 2004;147:331\u20138.","journal-title":"Am Heart J"},{"key":"1017_CR29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000164149","volume":"113","author":"WF Peacock","year":"2009","unstructured":"Peacock WF, Costanzo MR, De Marco T, Lopatin M, Wynne J, Mills RM, et al. Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry. Cardiology. 2009;113:12\u20139.","journal-title":"Cardiology"},{"key":"1017_CR30","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ahj.2010.05.032","volume":"160","author":"HM Abdel-Qadir","year":"2010","unstructured":"Abdel-Qadir HM, Tu JV, Yun L, Austin PC, Newton GE, Lee DS. Diuretic dose and long-term outcomes in elderly patients with heart failure after hospitalization. Am Heart J. 2010;160:264\u201371.","journal-title":"Am Heart J"},{"key":"1017_CR31","volume":"3","author":"DR Salvador","year":"2005","unstructured":"Salvador DR, Rey NR, Ramos GC, Punzalan FE. Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev. 2005;3:CD003178.","journal-title":"Cochrane Database Syst Rev"},{"key":"1017_CR32","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ahj.2012.08.019","volume":"164","author":"RV Shah","year":"2012","unstructured":"Shah RV, McNulty S, O\u2019Connor CM, Felker GM, Braunwald E, Givertz MM. Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure. Am Heart J. 2012;164:862\u20138.","journal-title":"Am Heart J"},{"key":"1017_CR33","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.ijcard.2012.05.004","volume":"167","author":"S Ather","year":"2013","unstructured":"Ather S, Bavishi C, McCauley MD, Dhaliwal A, Deswal A, Johnson S, et al. Worsening renal function is not associated with response to treatment in acute heart failure. Int J Cardiol. 2013;167:1912\u20137.","journal-title":"Int J Cardiol"},{"key":"1017_CR34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/CIRCHEARTFAILURE.111.963413","volume":"5","author":"M Metra","year":"2012","unstructured":"Metra M, Davison B, Bettari L, Sun H, Edwards C, Lazzarini V, et al. Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail. 2012;5:54\u201362.","journal-title":"Circ Heart Fail"},{"key":"1017_CR35","doi-asserted-by":"crossref","unstructured":"N\u00fa\u00f1ez J, Garcia S, N\u00fa\u00f1ez E, Bonanad C, Bod\u00ed V, Mi\u00f1ana G, et al. Early serum creatinine changes and outcomes in patients admitted for acute heart failure: the cardio-renal syndrome revisited. Eur Heart J Acute Cardiovasc Care. 2014 Jul 30. [Epub ahead of print].","DOI":"10.1177\/2048872614540094"},{"key":"1017_CR36","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/ejhf.170","volume":"16","author":"AA Voors","year":"2014","unstructured":"Voors AA, Davison BA, Teerlink JR, Felker GM, Cotter G, Filippatos G, et al. Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome\u2014an analysis from RELAX-AHF. Eur J Heart Fail. 2014;16:1230\u201340.","journal-title":"Eur J Heart Fail"},{"key":"1017_CR37","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jacc.2012.11.005","volume":"61","author":"M Metra","year":"2013","unstructured":"Metra M, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, et al. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. J Am Coll Cardiol. 2013;61:196\u2013206.","journal-title":"J Am Coll Cardiol"},{"key":"1017_CR38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jchf.2014.09.003","volume":"3","author":"RJ Mentz","year":"2015","unstructured":"Mentz RJ, Stevens SR, DeVore AD, Lala A, Vader JM, AbouEzzeddine OF, et al. Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure. JACC Heart Fail. 2015;3:97\u2013107.","journal-title":"JACC Heart Fail"},{"key":"1017_CR39","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.cardfail.2014.08.008","volume":"20","author":"JM Testani","year":"2014","unstructured":"Testani JM, Damman K, Brisco MA, Chen S, Laur O, Kula AJ, et al. A combined-biomarker approach to clinical phenotyping renal dysfunction in heart failure. J Card Fail. 2014;20:912\u20139.","journal-title":"J Card Fail"},{"key":"1017_CR40","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jchf.2014.10.005","volume":"3","author":"FH Verbrugge","year":"2015","unstructured":"Verbrugge FH, Tang WH, Mullens W. Renin-angiotensin-aldosterone system activation during decongestion in acute heart failure: friend or foe? JACC Heart Fail. 2015;3:108\u201311.","journal-title":"JACC Heart Fail"},{"key":"1017_CR41","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrcardio.2014.215","volume":"12","author":"JM Ter Maaten","year":"2015","unstructured":"Ter Maaten JM, Valente MA, Damman K, Hillege HL, Navis G, Voors AA. Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy. Nat Rev Cardiol. 2015;12:184\u201392.","journal-title":"Nat Rev Cardiol"},{"key":"1017_CR42","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s11936-014-0330-5","volume":"16","author":"SF Shakar","year":"2014","unstructured":"Shakar SF, Lindenfeld J. Treatment approaches to congestion relief in acute decompensated hf: insights After DOSE-AHF and CARRESS-HF. Curr Treat Options Cardiovasc Med. 2014;16:330.","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"1017_CR43","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1553-2712.2008.00059.x","volume":"15","author":"TA Tallman","year":"2008","unstructured":"Tallman TA, Peacock WF, Emerman CL, Lopatin M, Blicker JZ, Weber J, et al. Noninvasive ventilation outcomes in 2,430 acute decompensated heart failure patients: an ADHERE registry analysis. Acad Emerg Med. 2008;15:355\u201362.","journal-title":"Acad Emerg Med"},{"key":"1017_CR44","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/CIRCHEARTFAILURE.113.000698","volume":"7","author":"VT Kulkarni","year":"2014","unstructured":"Kulkarni VT, Kim N, Dai Y, Dharmarajan K, Safavi KC, Bikdeli B, et al. Hospital variation in noninvasive positive pressure ventilation for acute decompensated heart failure. Circ Heart Fail. 2014;7:427\u201333.","journal-title":"Circ Heart Fail"},{"key":"1017_CR45","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/2048872613492440","volume":"2","author":"T Tarvasmaki","year":"2013","unstructured":"Tarvasmaki T, Harjola VP, Tolonen J, Siirila-Waris K, Nieminen MS, Lassus J, et al. Management of acute heart failure and the effect of systolic blood pressure on the use of intravenous therapies. Eur Heart J Acute Cardiovasc Care. 2013;2:219\u201325.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"1017_CR46","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1161\/CIRCULATIONAHA.113.003046","volume":"130","author":"VM van Deursen","year":"2014","unstructured":"van Deursen VM, Hernandez AF, Stebbins A, Hasselblad V, Ezekowitz JA, Califf RM, et al. Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF). Circulation. 2014;130:958\u201365.","journal-title":"Circulation"},{"key":"1017_CR47","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1161\/01.CIR.0000070422.41439.04","volume":"107","author":"M Gheorghiade","year":"2003","unstructured":"Gheorghiade M, Niazi I, Ouyang J, Czerwiec F, Kambayashi J, Zampino M, et al. Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial. Circulation. 2003;107:2690\u20136.","journal-title":"Circulation"},{"key":"1017_CR48","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cardfail.2014.03.006","volume":"20","author":"D Singh","year":"2014","unstructured":"Singh D, Shrestha K, Testani JM, Verbrugge FH, Dupont M, Mullens W, et al. Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure. J Card Fail. 2014;20:392\u20139.","journal-title":"J Card Fail"},{"key":"1017_CR49","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCHEARTFAILURE.113.000895","volume":"7","author":"JM Testani","year":"2014","unstructured":"Testani JM, Brisco MA, Turner JM, Spatz ES, Bellumkonda L, Parikh CR, et al. Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure. Circ Heart Fail. 2014;7:261\u201370.","journal-title":"Circ Heart Fail"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-015-1017-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-015-1017-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-015-1017-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-015-1017-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T06:19:05Z","timestamp":1676355545000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-015-1017-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,1]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12]]}},"alternative-id":["1017"],"URL":"https:\/\/doi.org\/10.1186\/s13054-015-1017-3","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,1]]},"assertion":[{"value":"1 December 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"296"}}